Radiation therapy firm North American Scientific (NAS) reported that its Nomos radiation oncology division has received 510(k) clearance from the Food and Drug Administration to market nTRAK, a new stereotactic image guidance system used to position and monitor patients during radiation therapy treatments for head and neck cancers.
The product utilizes an optical camera and fiducial markers attached to a customized bite block to ensure that a patient is positioned reproducibly within required tolerances throughout a course of radiation therapy treatments, according to the Chatsworth, CA-based firm. NAS said it expects sales of nTRAK to begin in its fiscal 2005 fourth quarter.
By AuntMinnie.com staff writers
July 8, 2005
Related Reading
Nomos acquisition boosts NAS revenues, June 8, 2005
NAS files quarterly 10-Q report, April 18, 2005
NAS gets Nasdaq delisting notice, March 28, 2005
NAS posts record revenues, but loss widens, March 14, 2005
California install for Nomos, January 11, 2005
Copyright © 2005 AuntMinnie.com